首页 > 最新文献

Surgery for Obesity and Related Diseases最新文献

英文 中文
Metabolic disease remission after Roux-en-Y gastric bypass depends on preoperative disease severity: use of a new objective metabolic scoring system Roux-en-Y 胃旁路术后代谢性疾病的缓解取决于术前疾病的严重程度:使用新的客观代谢评分系统
IF 3.1 3区 医学 Q1 SURGERY Pub Date : 2024-08-17 DOI: 10.1016/j.soard.2024.08.022
Annie Wang M.D., Victoria Lyo M.D. M.T.M., John C. Lew M.S. R.D., Tiffany L. Wong B.S., Sandra L. Taylor Ph.D., Zainab Akinjobi M.Sc., Hazem N. Shamseddeen M.D., Shushmita M. Ahmed M.D. D.A.B.O.M., Mohamed R. Ali M.D. F.A.C.S. F.A.S.M.B.S.
Severity stratification and longitudinal evaluation of metabolic conditions in response to Roux-en-Y gastric bypass (RYGB) are not standardized. Our Assessment of Obesity-related Metabolic Comorbidities (AOMC) scoring tool combines pharmacotherapy and biochemical data to objectively define type 2 diabetes (T2D), hypertension (HTN), and dyslipidemia (DYS) severity. We previously showed that AOMC more accurately describes disease severity than clinical history alone. We aimed to show that AOMC more precisely and reproducibly measures metabolic disease response to RYGB and preoperative disease severity influences remission rates. University hospital, United States. AOMC scores for T2D, DYS, and HTN were calculated preoperatively and postoperatively (1-, 2-, and 5-years) for patients who underwent RYGB over 14 years. Generalized linear mixed-effect models were used to evaluate AOMC score trends and remission over time. Of 351 patients, 214, 188, and 303, presented with any T2D, DYS, or HTN respectively. One-year remission rates were: T2D 57.1%, DYS 59.7%, and HTN 29.3%. Over 5 years post-RYGB, remission rates declined for T2D ( < .05) and DYS ( < .05) but remained steady for HTN ( > .05). Remission was associated with preoperative disease severity: those with premetabolic disease had the highest remission rates (i.e., 1-year: pre-T2D 81.4%, pre-DYS 91.4%, pre-HTN 53.5%, all < .05), while those with most severe scores preoperatively (untreated/uncontrolled) had the lowest remission rates. AOMC allows precise assessment of comorbidity severity and disease-specific postoperative quantification of comorbidity responses and remission rates. These findings can guide preoperative metabolic disease optimization and postoperative metabolic recovery expectations and standardize communication regarding comorbidity severity.
对 Roux-en-Y 胃旁路术(RYGB)代谢状况的严重程度分层和纵向评估尚未标准化。我们的 "肥胖相关代谢合并症评估"(AOMC)评分工具结合了药物治疗和生化数据,可客观界定 2 型糖尿病(T2D)、高血压(HTN)和血脂异常(DYS)的严重程度。我们以前的研究表明,AOMC 比单纯的临床病史更能准确地描述疾病的严重程度。我们的目标是证明 AOMC 能够更准确、更可重复地测量代谢性疾病对 RYGB 的反应,以及术前疾病严重程度对缓解率的影响。美国大学医院。对14年来接受RYGB手术的患者进行术前和术后(1年、2年和5年)T2D、DYS和HTN的AOMC评分计算。采用广义线性混合效应模型评估AOMC评分趋势和随时间变化的缓解情况。在351名患者中,分别有214人、188人和303人患有T2D、DYS或高血压。一年缓解率分别为T2D缓解率为57.1%,DYS缓解率为59.7%,高血压缓解率为29.3%。RYGB术后5年,T2D(< .05)和DYS(< .05)的缓解率有所下降,但高血压(> .05)的缓解率保持稳定。缓解率与术前疾病严重程度有关:代谢前疾病患者的缓解率最高(即1年:T2D术前81.4%,DYS术前91.4%,HTN术前53.5%,均< .05),而术前评分最严重(未治疗/未控制)的患者缓解率最低。AOMC可以精确评估合并症的严重程度,并在术后量化合并症的反应和缓解率。这些发现可以指导术前代谢疾病优化和术后代谢恢复预期,并规范有关合并症严重程度的沟通。
{"title":"Metabolic disease remission after Roux-en-Y gastric bypass depends on preoperative disease severity: use of a new objective metabolic scoring system","authors":"Annie Wang M.D., Victoria Lyo M.D. M.T.M., John C. Lew M.S. R.D., Tiffany L. Wong B.S., Sandra L. Taylor Ph.D., Zainab Akinjobi M.Sc., Hazem N. Shamseddeen M.D., Shushmita M. Ahmed M.D. D.A.B.O.M., Mohamed R. Ali M.D. F.A.C.S. F.A.S.M.B.S.","doi":"10.1016/j.soard.2024.08.022","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.022","url":null,"abstract":"Severity stratification and longitudinal evaluation of metabolic conditions in response to Roux-en-Y gastric bypass (RYGB) are not standardized. Our Assessment of Obesity-related Metabolic Comorbidities (AOMC) scoring tool combines pharmacotherapy and biochemical data to objectively define type 2 diabetes (T2D), hypertension (HTN), and dyslipidemia (DYS) severity. We previously showed that AOMC more accurately describes disease severity than clinical history alone. We aimed to show that AOMC more precisely and reproducibly measures metabolic disease response to RYGB and preoperative disease severity influences remission rates. University hospital, United States. AOMC scores for T2D, DYS, and HTN were calculated preoperatively and postoperatively (1-, 2-, and 5-years) for patients who underwent RYGB over 14 years. Generalized linear mixed-effect models were used to evaluate AOMC score trends and remission over time. Of 351 patients, 214, 188, and 303, presented with any T2D, DYS, or HTN respectively. One-year remission rates were: T2D 57.1%, DYS 59.7%, and HTN 29.3%. Over 5 years post-RYGB, remission rates declined for T2D ( < .05) and DYS ( < .05) but remained steady for HTN ( > .05). Remission was associated with preoperative disease severity: those with premetabolic disease had the highest remission rates (i.e., 1-year: pre-T2D 81.4%, pre-DYS 91.4%, pre-HTN 53.5%, all < .05), while those with most severe scores preoperatively (untreated/uncontrolled) had the lowest remission rates. AOMC allows precise assessment of comorbidity severity and disease-specific postoperative quantification of comorbidity responses and remission rates. These findings can guide preoperative metabolic disease optimization and postoperative metabolic recovery expectations and standardize communication regarding comorbidity severity.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anastomotic metabolic and bariatric surgeries with same-day discharge: 30-day outcomes of a cohort from a high-volume center in Canada 当天出院的吻合代谢和减肥手术:来自加拿大一个高流量中心的一组患者的 30 天疗效
IF 3.1 3区 医学 Q1 SURGERY Pub Date : 2024-08-16 DOI: 10.1016/j.soard.2024.08.020
Alexis Deffain M.D., Ronald Denis M.D., Heba Alfaris M.D., Karim Ataya M.D., Samah Melebari M.D., Marc Belliveau M.D., Adam Di Palma M.D., Pierre Garneau M.D., Anne-Sophie Studer M.D.
On the basis of our extensive experience in same-day discharge (SDD) sleeve gastrectomy, we extended this management strategy to anastomotic metabolic and bariatric surgeries (MBS). To retrospectively analyze early outcomes (≤30 d) after anastomotic MBS with planned SDD (≤12 hr). University Hospital, Canada; Public Practice. SDD anastomotic MBS were proposed with strict preoperative criteria and included single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S), Roux-en-Y gastric bypass (RYGB), one-anastomosis gastric bypass (OAGB), and single-anastomosis sleeve ileal bypass (SASI). Enhanced recovery after bariatric surgery protocols and post-anesthesia care unit criteria were followed. Unplanned overnight stay, emergency department (ED) visit, readmission, morbidity-mortality, and reintervention rates were analyzed. Since 2021, 208 patients (191 female and 17 male) have undergone SDD anastomotic MBS, with 76% conversion procedures: 92 SADI-S, 72 RYGB, 35 OAGB, and 9 SASI (mean age = 41.4 yr and mean preoperative body mass index = 41.9 kg/m). Unplanned overnight stays and ED visits were 4.8% and 4.3%, respectively. Readmission rate was 5.8% (5 SADI-S, 5 RYGB, 1 OAGB, and 1 SASI). Overall morbidity rate was 14.9%, including 3.9% major complications. Within 30 days postoperatively, there were 2 duodenal leaks, 1 intrabdominal collection, 1 common bile duct stenosis, and 1 acute appendicitis in the SADI-S group. There were 2 occlusions on the jejunojejunal anastomosis and 1 bleeding on the gastrojejunal anastomosis in the RYGB group. Five (2.4%) required reintervention with no mortality. We report low and acceptable rates of unplanned overnight stay, readmission, and reintervention. Early outcomes suggest that SDD anastomotic MBS seems safe and feasible with an experienced team, selective criteria, and appropriate postoperative follow-up.
基于我们在当天出院(SDD)袖状胃切除术中积累的丰富经验,我们将这一管理策略推广到了吻合口代谢和减肥手术(MBS)中。回顾性分析吻合口 MBS 术后早期(≤30 天)的疗效,并计划 SDD(≤12 小时)。加拿大大学医院;公共实践。SDD吻合器MBS的提出有严格的术前标准,包括单吻合十二指肠-回肠旁路袖带胃切除术(SADI-S)、Roux-en-Y胃旁路术(RYGB)、单吻合胃旁路术(OAGB)和单吻合袖带回肠旁路术(SASI)。遵循减肥手术后强化恢复方案和麻醉后护理病房标准。对计划外过夜、急诊科就诊、再入院、发病率-死亡率和再干预率进行了分析。自 2021 年以来,共有 208 名患者(191 名女性和 17 名男性)接受了 SDD 吻合器 MBS,其中 76% 接受了转换手术:92 例 SADI-S、72 例 RYGB、35 例 OAGB 和 9 例 SASI(平均年龄 = 41.4 岁,术前平均体重指数 = 41.9 kg/m)。计划外过夜率和急诊就诊率分别为 4.8% 和 4.3%。再入院率为 5.8%(5 例 SADI-S、5 例 RYGB、1 例 OAGB 和 1 例 SASI)。总发病率为 14.9%,包括 3.9% 的主要并发症。术后 30 天内,SADI-S 组有 2 例十二指肠漏、1 例腹腔积液、1 例总胆管狭窄和 1 例急性阑尾炎。RYGB 组有 2 例空肠吻合口闭塞,1 例胃空肠吻合口出血。5例(2.4%)需要再次手术,无死亡病例。我们的报告显示,计划外过夜、再次入院和再次手术的发生率较低且可以接受。早期结果表明,只要有经验丰富的团队、选择性标准和适当的术后随访,SDD 吻合器 MBS 似乎是安全可行的。
{"title":"Anastomotic metabolic and bariatric surgeries with same-day discharge: 30-day outcomes of a cohort from a high-volume center in Canada","authors":"Alexis Deffain M.D., Ronald Denis M.D., Heba Alfaris M.D., Karim Ataya M.D., Samah Melebari M.D., Marc Belliveau M.D., Adam Di Palma M.D., Pierre Garneau M.D., Anne-Sophie Studer M.D.","doi":"10.1016/j.soard.2024.08.020","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.020","url":null,"abstract":"On the basis of our extensive experience in same-day discharge (SDD) sleeve gastrectomy, we extended this management strategy to anastomotic metabolic and bariatric surgeries (MBS). To retrospectively analyze early outcomes (≤30 d) after anastomotic MBS with planned SDD (≤12 hr). University Hospital, Canada; Public Practice. SDD anastomotic MBS were proposed with strict preoperative criteria and included single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S), Roux-en-Y gastric bypass (RYGB), one-anastomosis gastric bypass (OAGB), and single-anastomosis sleeve ileal bypass (SASI). Enhanced recovery after bariatric surgery protocols and post-anesthesia care unit criteria were followed. Unplanned overnight stay, emergency department (ED) visit, readmission, morbidity-mortality, and reintervention rates were analyzed. Since 2021, 208 patients (191 female and 17 male) have undergone SDD anastomotic MBS, with 76% conversion procedures: 92 SADI-S, 72 RYGB, 35 OAGB, and 9 SASI (mean age = 41.4 yr and mean preoperative body mass index = 41.9 kg/m). Unplanned overnight stays and ED visits were 4.8% and 4.3%, respectively. Readmission rate was 5.8% (5 SADI-S, 5 RYGB, 1 OAGB, and 1 SASI). Overall morbidity rate was 14.9%, including 3.9% major complications. Within 30 days postoperatively, there were 2 duodenal leaks, 1 intrabdominal collection, 1 common bile duct stenosis, and 1 acute appendicitis in the SADI-S group. There were 2 occlusions on the jejunojejunal anastomosis and 1 bleeding on the gastrojejunal anastomosis in the RYGB group. Five (2.4%) required reintervention with no mortality. We report low and acceptable rates of unplanned overnight stay, readmission, and reintervention. Early outcomes suggest that SDD anastomotic MBS seems safe and feasible with an experienced team, selective criteria, and appropriate postoperative follow-up.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron homeostasis in obesity and metabolic and bariatric surgery: a narrative review 肥胖、代谢和减肥手术中的铁平衡:叙述性综述
IF 3.1 3区 医学 Q1 SURGERY Pub Date : 2024-08-16 DOI: 10.1016/j.soard.2024.08.018
Peter N. Benotti M.D., Jila Kaberi-Otarod M.D., G. Craig Wood M.D., Glenn S. Gerhard M.D., Christopher D. Still D.O., Bruce R. Bistrian M.D. Ph.D.
Iron deficiency has been recognized as a potentially modifiable nutritional complication of metabolic and bariatric surgery (MBS) since prior to the turn of the century. Despite this, it remains the most common and clinically significant nutritional complication of this surgery with the potential to negate quality of live and the health benefits of surgical weight loss. This narrative review summarizes the current literature regarding iron deficiency as it relates to patients with severe obesity and those who undergo MBS. Advances in the clinical knowledge of iron homeostasis in severe obesity as a chronic disease, current diagnostic criteria for the diagnosis of iron deficiency in this patient population, the significance of preoperative iron deficiency, postoperative iron deficiency, and the status of supplementation and treatment will be reviewed with emphasis on gaps in knowledge and needed areas of further study.
早在本世纪初,人们就已经认识到铁缺乏症是代谢和减肥手术(MBS)的一种潜在营养并发症。尽管如此,铁缺乏症仍然是该手术最常见、最具临床意义的营养并发症,有可能影响生活质量和手术减肥的健康益处。这篇叙述性综述总结了目前有关铁缺乏症的文献,因为它与重度肥胖症患者和接受 MBS 的患者有关。将回顾重度肥胖作为一种慢性疾病的铁平衡临床知识的进展、当前诊断该患者群体缺铁的诊断标准、术前缺铁的意义、术后缺铁以及补充和治疗的现状,并重点关注知识差距和需要进一步研究的领域。
{"title":"Iron homeostasis in obesity and metabolic and bariatric surgery: a narrative review","authors":"Peter N. Benotti M.D., Jila Kaberi-Otarod M.D., G. Craig Wood M.D., Glenn S. Gerhard M.D., Christopher D. Still D.O., Bruce R. Bistrian M.D. Ph.D.","doi":"10.1016/j.soard.2024.08.018","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.018","url":null,"abstract":"Iron deficiency has been recognized as a potentially modifiable nutritional complication of metabolic and bariatric surgery (MBS) since prior to the turn of the century. Despite this, it remains the most common and clinically significant nutritional complication of this surgery with the potential to negate quality of live and the health benefits of surgical weight loss. This narrative review summarizes the current literature regarding iron deficiency as it relates to patients with severe obesity and those who undergo MBS. Advances in the clinical knowledge of iron homeostasis in severe obesity as a chronic disease, current diagnostic criteria for the diagnosis of iron deficiency in this patient population, the significance of preoperative iron deficiency, postoperative iron deficiency, and the status of supplementation and treatment will be reviewed with emphasis on gaps in knowledge and needed areas of further study.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of conversional metabolic bariatric surgery on dyslipidemia and the cost of lipid-lowering medications over 4 years: a French nationwide study 转换代谢减肥手术对血脂异常和四年内降脂药物费用的影响:一项法国全国性研究
IF 3.1 3区 医学 Q1 SURGERY Pub Date : 2024-08-16 DOI: 10.1016/j.soard.2024.08.019
Jérémie Thereaux M.D. Ph.D., Mohammed Bennani, Jean Khemis, Elisabeth Ohayon, Isabelle Visnovec Buissez, Alexandre Lafourcade, Laëtitia Quiriconi, Caroline Philippe, Jean-Michel Oppert
The need for conversional metabolic bariatric surgery (CMBS) is still growing. No large-scale prospective cohort studies have assessed changes in lipid-lowering treatment (LLT) after CMBS. This study assesses and compares the effectiveness of the 4 main CMBS sequences after sleeve gastrectomy (SG) and adjustable gastric banding (AGB) on reimbursement and cost of LLT. France. This nationwide observational population-based cohort study analyzed data from the French National Health Insurance database. It included all patients who had undergone primary SG and AGB in France between January 1, 2012, and December 31, 2014, and followed until December 31, 2020. The study assessed LLT reimbursement evolution and costs across 4 different CMBS sequences. During follow-up, 6396 patients underwent the 4 CMBS sequences: SG-RYGB (Roux-en-Y gastric bypass) (n = 2400), AGB-SG (n = 2277), AGB-RYGB (n = 1173), and SG-SG (n = 546), with a rate of LLT reimbursement of 9.8%, 3.6%, 6.6%, and 7.9%, respectively, in the year before CMBS. The rates of discontinuation of treatment at 2 and 4 years were 41.9%, 35.4%, 45.6%, 20.5% and 45.6%, 31.3%, 64.3%, 31.6%, respectively. At 4 years, the median [interquartile range] annual costs (euros) per patient were significantly lower ( < .01) than the costs in the year before CMBS for each sequence: 86.8 [57.3; 136.1] versus 38.0 [.0; 64.6], 79.1 [50.5; 120.1] versus 50.4 [15.6; 64.1], 89.0 [66.5; 139.6] versus .0 [.0; 58.8], and 89.8 [66.1; 121.4] versus 63.1 [.0; 93.4]. Our study underlines the effectiveness of CMBS in significantly reducing the need and associated costs of LLT for patients with dyslipidemia over a 4-year period.
转换代谢减肥手术(CMBS)的需求仍在不断增长。目前还没有大规模的前瞻性队列研究对 CMBS 术后降脂治疗(LLT)的变化进行评估。本研究评估并比较了袖带胃切除术(SG)和可调节胃束带术(AGB)后 4 种主要 CMBS 顺序对 LLT 报销和成本的影响。法国。这项基于人群的全国性观察性队列研究分析了法国国家健康保险数据库中的数据。该研究纳入了 2012 年 1 月 1 日至 2014 年 12 月 31 日期间在法国接受过初级 SG 和 AGB 手术的所有患者,并跟踪研究至 2020 年 12 月 31 日。研究评估了 4 种不同的 CMBS 序列的 LLT 报销演变和成本。在随访期间,6396 名患者接受了 4 种 CMBS 顺序治疗:SG-RYGB(Roux-en-Y 胃旁路术)(n = 2400)、AGB-SG(n = 2277)、AGB-RYGB(n = 1173)和 SG-SG(n = 546),CMBS 前一年的 LLT 报销率分别为 9.8%、3.6%、6.6% 和 7.9%。2 年和 4 年后停止治疗的比例分别为 41.9%、35.4%、45.6%、20.5% 和 45.6%、31.3%、64.3%、31.6%。4年后,每名患者的年度费用(欧元)中位数[四分位数间距]明显低于CMBS前一年的费用(< .01):86.8 [57.3; 136.1] 对 38.0 [.0; 64.6],79.1 [50.5; 120.1] 对 50.4 [15.6; 64.1],89.0 [66.5; 139.6] 对 .0 [.0; 58.8],以及 89.8 [66.1; 121.4] 对 63.1 [.0; 93.4]。我们的研究强调了 CMBS 在 4 年内显著降低血脂异常患者对 LLT 的需求和相关费用方面的有效性。
{"title":"Effectiveness of conversional metabolic bariatric surgery on dyslipidemia and the cost of lipid-lowering medications over 4 years: a French nationwide study","authors":"Jérémie Thereaux M.D. Ph.D., Mohammed Bennani, Jean Khemis, Elisabeth Ohayon, Isabelle Visnovec Buissez, Alexandre Lafourcade, Laëtitia Quiriconi, Caroline Philippe, Jean-Michel Oppert","doi":"10.1016/j.soard.2024.08.019","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.019","url":null,"abstract":"The need for conversional metabolic bariatric surgery (CMBS) is still growing. No large-scale prospective cohort studies have assessed changes in lipid-lowering treatment (LLT) after CMBS. This study assesses and compares the effectiveness of the 4 main CMBS sequences after sleeve gastrectomy (SG) and adjustable gastric banding (AGB) on reimbursement and cost of LLT. France. This nationwide observational population-based cohort study analyzed data from the French National Health Insurance database. It included all patients who had undergone primary SG and AGB in France between January 1, 2012, and December 31, 2014, and followed until December 31, 2020. The study assessed LLT reimbursement evolution and costs across 4 different CMBS sequences. During follow-up, 6396 patients underwent the 4 CMBS sequences: SG-RYGB (Roux-en-Y gastric bypass) (n = 2400), AGB-SG (n = 2277), AGB-RYGB (n = 1173), and SG-SG (n = 546), with a rate of LLT reimbursement of 9.8%, 3.6%, 6.6%, and 7.9%, respectively, in the year before CMBS. The rates of discontinuation of treatment at 2 and 4 years were 41.9%, 35.4%, 45.6%, 20.5% and 45.6%, 31.3%, 64.3%, 31.6%, respectively. At 4 years, the median [interquartile range] annual costs (euros) per patient were significantly lower ( < .01) than the costs in the year before CMBS for each sequence: 86.8 [57.3; 136.1] versus 38.0 [.0; 64.6], 79.1 [50.5; 120.1] versus 50.4 [15.6; 64.1], 89.0 [66.5; 139.6] versus .0 [.0; 58.8], and 89.8 [66.1; 121.4] versus 63.1 [.0; 93.4]. Our study underlines the effectiveness of CMBS in significantly reducing the need and associated costs of LLT for patients with dyslipidemia over a 4-year period.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sociodemographic factors related to bariatric follow-up appointment attendance and weight outcomes 与减肥复诊出席率和体重结果相关的社会人口因素
IF 3.1 3区 医学 Q1 SURGERY Pub Date : 2024-08-13 DOI: 10.1016/j.soard.2024.08.010
Emily M. Bartholomay Ph.D., Stephanie Cox Ph.D., Lawrence Tabone M.D., Nova Szoka M.D., Salim Abunnaja M.D., Laura Aylward Ph.D.
Follow-up care after bariatric surgery is essential in preventing postsurgical complications and promoting long-term weight loss maintenance. However, many patients do not attend postsurgical appointments with the bariatric team, which may contribute to poor surgical outcomes. This study sought to understand sociodemographic factors related to follow-up appointment attendance and weight outcomes. The first objective was to determine whether there was a relationship between 1-year follow-up appointment attendance and sociodemographic factors. The second objective was to determine whether patients from certain sociodemographic groups were more likely to attend a 2-year follow-up appointment. The third objective was to determine whether there were differences in weight outcomes for patients who attended follow-up appointments compared with those who did not attend. University hospital, United States. This study was a retrospective observational study. Participants included 841 adult patients who underwent bariatric surgery, of whom 505 (60.05%) attended a 1-year appointment with the bariatric team (348 attended a follow-up visit with another medical provider), and 398 (47.32%) who had any follow-up medical visit at 2 years after surgery. Sociodemographic variables were collected during a presurgical psychological evaluation. Weight-related variables were obtained through patients’ electronic medical records 12 and 24 months after surgery. Younger patients and those with lower education levels were less likely to attend the 1-year follow-up appointment with the bariatric team. People who attend 1-year follow-up with bariatric team have more favorable weight outcomes at 1 year and 2 years after surgery. Follow-up appointment attendance with the bariatric team may be a critical factor in the effectiveness of bariatric surgery. Bariatric surgery teams should employ strategies to increase attendance at the 1-year follow-up visit with the surgical team. Additional strategies should be enacted to increase follow-up appointment attendance for patients with lower education levels.
减肥手术后的后续护理对于预防手术后并发症和促进长期减肥效果的维持至关重要。然而,许多患者在手术后并没有与减肥团队预约随访,这可能会导致手术效果不佳。本研究旨在了解与复诊出席率和体重结果相关的社会人口学因素。第一个目标是确定一年随访预约出席率与社会人口学因素之间是否存在关系。第二个目标是确定某些社会人口学群体的患者是否更有可能参加为期 2 年的复诊。第三个目标是确定参加随访的患者与未参加随访的患者在体重结果上是否存在差异。美国大学医院。该研究是一项回顾性观察研究。参与者包括 841 名接受减肥手术的成年患者,其中 505 人(60.05%)接受了减肥团队为期 1 年的随访(348 人接受了其他医疗机构的随访),398 人(47.32%)在术后 2 年接受了任何随访。社会人口学变量是在术前心理评估中收集的。与体重相关的变量通过患者术后 12 个月和 24 个月的电子病历获得。较年轻的患者和教育程度较低的患者较少参加减肥小组的 1 年随访。参加减肥小组 1 年随访的患者在术后 1 年和 2 年的体重结果更理想。参加减肥团队的随访可能是减肥手术效果的关键因素。减肥手术团队应采取策略,提高手术团队 1 年随访的出席率。还应制定其他策略,提高教育程度较低患者的随访出席率。
{"title":"Sociodemographic factors related to bariatric follow-up appointment attendance and weight outcomes","authors":"Emily M. Bartholomay Ph.D., Stephanie Cox Ph.D., Lawrence Tabone M.D., Nova Szoka M.D., Salim Abunnaja M.D., Laura Aylward Ph.D.","doi":"10.1016/j.soard.2024.08.010","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.010","url":null,"abstract":"Follow-up care after bariatric surgery is essential in preventing postsurgical complications and promoting long-term weight loss maintenance. However, many patients do not attend postsurgical appointments with the bariatric team, which may contribute to poor surgical outcomes. This study sought to understand sociodemographic factors related to follow-up appointment attendance and weight outcomes. The first objective was to determine whether there was a relationship between 1-year follow-up appointment attendance and sociodemographic factors. The second objective was to determine whether patients from certain sociodemographic groups were more likely to attend a 2-year follow-up appointment. The third objective was to determine whether there were differences in weight outcomes for patients who attended follow-up appointments compared with those who did not attend. University hospital, United States. This study was a retrospective observational study. Participants included 841 adult patients who underwent bariatric surgery, of whom 505 (60.05%) attended a 1-year appointment with the bariatric team (348 attended a follow-up visit with another medical provider), and 398 (47.32%) who had any follow-up medical visit at 2 years after surgery. Sociodemographic variables were collected during a presurgical psychological evaluation. Weight-related variables were obtained through patients’ electronic medical records 12 and 24 months after surgery. Younger patients and those with lower education levels were less likely to attend the 1-year follow-up appointment with the bariatric team. People who attend 1-year follow-up with bariatric team have more favorable weight outcomes at 1 year and 2 years after surgery. Follow-up appointment attendance with the bariatric team may be a critical factor in the effectiveness of bariatric surgery. Bariatric surgery teams should employ strategies to increase attendance at the 1-year follow-up visit with the surgical team. Additional strategies should be enacted to increase follow-up appointment attendance for patients with lower education levels.","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of a 6-month physical activity behavioral intervention in patients following metabolic bariatric surgery: a randomized controlled trial 为期 6 个月的体育锻炼行为干预对代谢性减肥手术后患者的影响:随机对照试验
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-08-13 DOI: 10.1016/j.soard.2024.08.017
Haya Subhi R.N., M.P.H. , Orly Manor Ph.D. , Ram Elazary M.D. , Dunia Kaluti R.D. , Tair Ben-Porat R.D., M.P.H., Ph.D.

Background

Promoting habitual physical activity (PA) among bariatric patients is crucial for long-term surgery success, yet it poses a significant challenge for healthcare practitioners.

Objectives

This randomized controlled trial (RCT) aimed to examine the effectiveness of a theory-based behavioral intervention on PA level in post-metabolic bariatric surgery (MBS) patients.

Setting

University Hospital, Israel

Methods

Forty-four patients undergoing MBS were randomized to the intervention (n = 22) or control group (n = 22). The intervention group received a 6-month PA counseling program based on self-determination theory (SDT) and the 5 A’s framework, while the control group received usual care. PA level and self-efficacy for exercise (SEE) were assessed pre- (baseline, preintervention) and postoperatively (14 and 28 weeks follow-ups). Anthropometrics, physical function, cardiovascular, and biochemical outcomes were measured at all time points.

Results

The intervention group showed greater increases in PA levels across time compared to the control group. A significant increase in step counts from baseline to 14 weeks was observed (P = .003). Significant differences favoring the intervention group were observed in self-reported PA changes from baseline to 14- and 28-week follow-ups (P = .020 and P = .024, respectively). Additionally, Physical function, as assessed by the 6-minute walk test (6MWT) and the 5 sit-to-stand (5STS) test, significantly improved in the intervention group throughout the follow-up period (P < .05 for all), However, no between-group differences were observed in SEE, anthropometrics, cardiovascular, or biochemical parameters.

Conclusions

A 6-month behavioral intervention post-MBS significantly enhanced patients' PA levels and physical function. Given its theory-based approach and structured protocol, this intervention could be disseminated to support MBS clinicians and centers. Further research with longer follow-up period is warranted to confirm these findings and assess the long-term effects.
促进肥胖症患者养成体育锻炼(PA)的习惯对于手术的长期成功至关重要,但这对医疗从业人员来说却是一项巨大的挑战。这项随机对照试验(RCT)旨在研究基于理论的行为干预对代谢性减肥手术(MBS)术后患者体育锻炼水平的影响。以色列大学医院 44 名接受代谢性减肥手术的患者被随机分配到干预组(22 人)或对照组(22 人)。干预组接受为期 6 个月的以自我决定理论(SDT)和 5 A 框架为基础的 PA 辅导计划,而对照组则接受常规护理。对干预前(基线,干预前)和干预后(14 周和 28 周随访)的运动量和运动自我效能(SEE)进行评估。在所有时间点都对人体测量学、身体功能、心血管和生化结果进行了测量。与对照组相比,干预组在不同时间段的运动量增加幅度更大。从基线到 14 周,观察到步数明显增加 ( = .003)。从基线到 14 周和 28 周的随访期间,干预组在自我报告的运动量变化方面有明显差异(分别为 = .020 和 = .024)。此外,通过 6 分钟步行测试 (6MWT) 和 5 次坐立测试 (5STS) 评估,干预组在整个随访期间的身体机能明显改善(均小于 0.05),但在 SEE、人体测量、心血管或生化指标方面未观察到组间差异。MBS后为期6个月的行为干预显著提高了患者的PA水平和身体功能。鉴于其基于理论的方法和结构化的方案,该干预措施可用于支持MBS临床医生和中心。为了证实这些研究结果并评估其长期效果,有必要进行更长时间的随访研究。
{"title":"Effects of a 6-month physical activity behavioral intervention in patients following metabolic bariatric surgery: a randomized controlled trial","authors":"Haya Subhi R.N., M.P.H. ,&nbsp;Orly Manor Ph.D. ,&nbsp;Ram Elazary M.D. ,&nbsp;Dunia Kaluti R.D. ,&nbsp;Tair Ben-Porat R.D., M.P.H., Ph.D.","doi":"10.1016/j.soard.2024.08.017","DOIUrl":"10.1016/j.soard.2024.08.017","url":null,"abstract":"<div><h3>Background</h3><div>Promoting habitual physical activity (PA) among bariatric patients is crucial for long-term surgery success, yet it poses a significant challenge for healthcare practitioners.</div></div><div><h3>Objectives</h3><div>This randomized controlled trial (RCT) aimed to examine the effectiveness of a theory-based behavioral intervention on PA level in post-metabolic bariatric surgery (MBS) patients.</div></div><div><h3>Setting</h3><div>University Hospital, Israel</div></div><div><h3>Methods</h3><div>Forty-four patients undergoing MBS were randomized to the intervention (n = 22) or control group (n = 22). The intervention group received a 6-month PA counseling program based on self-determination theory (SDT) and the 5 A’s framework, while the control group received usual care. PA level and self-efficacy for exercise (SEE) were assessed pre- (baseline, preintervention) and postoperatively (14 and 28 weeks follow-ups). Anthropometrics, physical function, cardiovascular, and biochemical outcomes were measured at all time points.</div></div><div><h3>Results</h3><div>The intervention group showed greater increases in PA levels across time compared to the control group. A significant increase in step counts from baseline to 14 weeks was observed (<em>P</em> = .003). Significant differences favoring the intervention group were observed in self-reported PA changes from baseline to 14- and 28-week follow-ups (<em>P</em> = .020 and <em>P</em> = .024, respectively). Additionally, Physical function, as assessed by the 6-minute walk test (6MWT) and the 5 sit-to-stand (5STS) test, significantly improved in the intervention group throughout the follow-up period (<em>P</em> &lt; .05 for all), However, no between-group differences were observed in SEE, anthropometrics, cardiovascular, or biochemical parameters.</div></div><div><h3>Conclusions</h3><div>A 6-month behavioral intervention post-MBS significantly enhanced patients' PA levels and physical function. Given its theory-based approach and structured protocol, this intervention could be disseminated to support MBS clinicians and centers. Further research with longer follow-up period is warranted to confirm these findings and assess the long-term effects.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting serious postoperative complications and evaluating racial fairness in machine learning algorithms for metabolic and bariatric surgery 预测术后严重并发症,评估代谢和减肥手术机器学习算法的种族公平性。
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-08-13 DOI: 10.1016/j.soard.2024.08.008
Dong-Won Kang Ph.D. , Shouhao Zhou Ph.D. , Russell Torres Ph.D. , Abhinandan Chowdhury Ph.D. , Suman Niranjan Ph.D. , Ann Rogers M.D. , Chan Shen Ph.D.

Background

Predicting the risk of complications is critical in metabolic and bariatric surgery (MBS).

Objectives

To develop machine learning (ML) models to predict serious postoperative complications of MBS and evaluate racial fairness of the models.

Setting

Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) national database, United States.

Methods

We developed logistic regression, random forest (RF), gradient-boosted tree (GBT), and XGBoost model using the MBSAQIP Participant Use Data File from 2016 to 2020. To address the class imbalance, we randomly undersampled the complication-negative class to match the complication-positive class. Model performance was evaluated using the area under the receiver operating characteristic curve (AUROC), precision, recall, and F1 score. Fairness across White and non-White patient groups was assessed using equal opportunity difference and disparate impact metrics.

Results

A total of 40,858 patients were included after undersampling the complication-negative class. The XGBoost model was the best-performing model in terms of AUROC; however, the difference was not statistically significant. While the F1 score and precision did not vary significantly across models, the RF exhibited better recall compared to the logistic regression. Surgery type was the most important feature to predict complications, followed by operative time. The logistic regression model had the best fairness metrics for race.

Conclusions

The XGBoost model achieved the highest AUROC, albeit without a statistically significant difference. The RF may be useful when recall is the primary concern. Undersampling of the privileged group may improve the fairness of boosted tree models.
背景:在代谢和减肥手术(MBS)中,预测并发症的风险至关重要:预测并发症风险对于代谢和减肥手术(MBS)至关重要:开发机器学习(ML)模型来预测代谢与减肥手术术后严重并发症,并评估模型的种族公平性:方法:我们开发了逻辑回归、随机聚类分析和 "MBS "模型,以预测MBS术后严重并发症:我们使用2016年至2020年的MBSAQIP参与者使用数据文件开发了逻辑回归、随机森林(RF)、梯度增强树(GBT)和XGBoost模型。为了解决类别不平衡的问题,我们随机对并发症阴性类别进行低采样,以匹配并发症阳性类别。模型性能使用接收者操作特征曲线下面积(AUROC)、精确度、召回率和 F1 分数进行评估。使用机会均等差异和差异影响指标对白人和非白人患者群体的公平性进行了评估:结果:在对并发症阴性患者进行低采样后,共纳入了 40858 名患者。就 AUROC 而言,XGBoost 模型是表现最好的模型,但差异在统计学上并不显著。虽然不同模型的 F1 得分和精确度差异不大,但 RF 与逻辑回归相比具有更好的召回率。手术类型是预测并发症的最重要特征,其次是手术时间。逻辑回归模型的种族公平性指标最好:XGBoost模型获得了最高的AUROC,尽管在统计学上没有显著差异。当召回率是主要考虑因素时,RF 可能会有用。对特权组进行低采样可能会提高提升树模型的公平性。
{"title":"Predicting serious postoperative complications and evaluating racial fairness in machine learning algorithms for metabolic and bariatric surgery","authors":"Dong-Won Kang Ph.D. ,&nbsp;Shouhao Zhou Ph.D. ,&nbsp;Russell Torres Ph.D. ,&nbsp;Abhinandan Chowdhury Ph.D. ,&nbsp;Suman Niranjan Ph.D. ,&nbsp;Ann Rogers M.D. ,&nbsp;Chan Shen Ph.D.","doi":"10.1016/j.soard.2024.08.008","DOIUrl":"10.1016/j.soard.2024.08.008","url":null,"abstract":"<div><h3>Background</h3><div>Predicting the risk of complications is critical in metabolic and bariatric surgery (MBS).</div></div><div><h3>Objectives</h3><div>To develop machine learning (ML) models to predict serious postoperative complications of MBS and evaluate racial fairness of the models.</div></div><div><h3>Setting</h3><div>Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) national database, United States.</div></div><div><h3>Methods</h3><div>We developed logistic regression, random forest (RF), gradient-boosted tree (GBT), and XGBoost model using the MBSAQIP Participant Use Data File from 2016 to 2020. To address the class imbalance, we randomly undersampled the complication-negative class to match the complication-positive class. Model performance was evaluated using the area under the receiver operating characteristic curve (AUROC), precision, recall, and F1 score. Fairness across White and non-White patient groups was assessed using equal opportunity difference and disparate impact metrics.</div></div><div><h3>Results</h3><div>A total of 40,858 patients were included after undersampling the complication-negative class. The XGBoost model was the best-performing model in terms of AUROC; however, the difference was not statistically significant. While the F1 score and precision did not vary significantly across models, the RF exhibited better recall compared to the logistic regression. Surgery type was the most important feature to predict complications, followed by operative time. The logistic regression model had the best fairness metrics for race.</div></div><div><h3>Conclusions</h3><div>The XGBoost model achieved the highest AUROC, albeit without a statistically significant difference. The RF may be useful when recall is the primary concern. Undersampling of the privileged group may improve the fairness of boosted tree models.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Beyond race: social vulnerability and access to metabolic and bariatric surgery 评论:超越种族:社会脆弱性与接受代谢和减肥手术的机会
IF 3.1 3区 医学 Q1 SURGERY Pub Date : 2024-08-10 DOI: 10.1016/j.soard.2024.08.009
Shaneeta Johnson M.D. M.B.A., Ryan Hill D.O., Tuesday Cook M.D., Larry Hobson M.D.
{"title":"Comment on: Beyond race: social vulnerability and access to metabolic and bariatric surgery","authors":"Shaneeta Johnson M.D. M.B.A., Ryan Hill D.O., Tuesday Cook M.D., Larry Hobson M.D.","doi":"10.1016/j.soard.2024.08.009","DOIUrl":"https://doi.org/10.1016/j.soard.2024.08.009","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142219369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Elevated HbA1C level and revisional bariatric surgery complications 评论HbA1C 水平升高与再次减肥手术并发症。
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-08-10 DOI: 10.1016/j.soard.2024.08.002
Adisa Poljo M.D., Jennifer M. Klasen M.D. Ph.D., Marko Kraljević M.D., Ralph Peterli M.D., Adrian T. Billeter M.D. Ph.D.
{"title":"Comment on: Elevated HbA1C level and revisional bariatric surgery complications","authors":"Adisa Poljo M.D.,&nbsp;Jennifer M. Klasen M.D. Ph.D.,&nbsp;Marko Kraljević M.D.,&nbsp;Ralph Peterli M.D.,&nbsp;Adrian T. Billeter M.D. Ph.D.","doi":"10.1016/j.soard.2024.08.002","DOIUrl":"10.1016/j.soard.2024.08.002","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Ambulatory discharge of patients undergoing sleeve gastrectomy results in significantly more adverse outcomes 评论接受袖带胃切除术的患者在非住院状态下出院会导致更多不良后果。
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2024-08-10 DOI: 10.1016/j.soard.2024.08.012
Daniel R. Cronk M.D., F.A.C.S., F.A.S.M.B.S., D.A.B.S.-F.P.D.M.B.S.
{"title":"Comment on: Ambulatory discharge of patients undergoing sleeve gastrectomy results in significantly more adverse outcomes","authors":"Daniel R. Cronk M.D., F.A.C.S., F.A.S.M.B.S., D.A.B.S.-F.P.D.M.B.S.","doi":"10.1016/j.soard.2024.08.012","DOIUrl":"10.1016/j.soard.2024.08.012","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142147259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery for Obesity and Related Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1